Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Research Agreement with Arysta LifeScience

27 Apr 2012 11:49

RNS Number : 2414C
Plant Health Care PLC
27 April 2012
 

27 April 2012

 

Plant Health Care plc

 

PLANT HEALTH CARE TO CONDUCT RESEARCH ON

HARPIN PROTEIN WITH ARYSTA LIFESCIENCE

 

 

Plant Health Care, a leading provider of naturally-derived products to the global agriculture markets, announces that it has signed a research agreement with Arysta LifeScience to evaluate Harpin commercially as a foliar spray in combination with a number of Arysta LifeScience's products.

 

 

Harpin is a leading PHC product and has been shown to increase yields significantly on a variety of crops when applied alone or in combination with other active ingredients. Arysta LifeScience will test Harpin formulations in combination with a number of its actives. Harpin technology offers yield improvement as a result of suppression of pests, such as nematodes, and defense against damaging diseases, as well as additive plant health benefits. Under this agreement, improvements in yield, plant health and product efficacy will be evaluated in a range of crops and environmental situations.

 

 

John Brady, CEO of Plant Health Care, commented: "We are excited to establish a testing programme with Arysta LifeScience, an innovative global player in the crop protection industry with annual sales of $1.6 billion. Arysta LifeScience has been highly successful in incorporating new technologies into its extensive product portfolio and, with its global reach, a successful outcome will be a major benefit to PHC. We are optimistic that Arysta LifeScience's testing efforts will lead to eventual commercial development of an innovative high return product for growers worldwide."

 

 

Bill Lewis, head of global business initiatives, Arysta LifeScience, said: "Harpin technology has the potential to bring additional value to Arysta LifeScience's existing line of products and we are excited about the opportunity to evaluate the Harpin technology."

 

 

- ENDS -

 

 

About Plant Health Care plc: Plant Health Care plc ("PHC") is a leading provider of naturally-derived products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC currently has approximately 40 employees and has operations in the United States, Mexico, the United Kingdom, Spain and the Netherlands. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") since February 2010 (ticker symbol/ mnemonic: PHC).

 

PHC's products are aimed at agriculture industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com.

 

 

 

For further information, please contact:

 

 

 

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

Stephen Weaver, Finance Director

Tel: +1-412-826-5488 x151

sweaver@planthealthcare.com

Nomura Code Securities

Tel: +44 (0) 20 7776 1200

Claire Terlouw / Chris Golden

www.nomuracode.com

Powerscourt

Tel: +44 (0) 20 7250 1446

Paul Durman / Nick Dibden

paul.durman@powerscourt-group.com

nick.dibden@powerscourt-group.com

 

 

 

 

 

About Arysta LifeScience Corporation

Headquartered in Tokyo, Japan, Arysta LifeScience is the world's largest privately held crop protection and life science company with 2011 revenues of JPY125.8 billion (US$1.6 billion). An entrepreneurial provider of crop protection and life science products in more than 125 countries worldwide, Arysta LifeScience specialises in marketing and distribution of respected crop protection brands and life science products in harmony with the needs of global partners. More information on the company is available at: www.arystalifescience.com.

 

Contact:

Linda Frerichs Global Communications Manager

Arysta LifeScience Corporation

919-678-4948

linda.frerichs@arystalifescience.com

 

Tara Hart Public Relations Manager

Woodruff Sweitzer

816-255-1960

thart@woodruffsweitzer.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAELXAFPAEFF
Date   Source Headline
21st Aug 20247:00 amRNSCancellation - Plant Health Care plc
20th Aug 202410:59 amRNSForm 8.5 (EPT/NON-RI)
20th Aug 202410:17 amRNSScheme of Arrangement becomes Effective
20th Aug 20247:30 amRNSSuspension - Plant Health Care plc
16th Aug 202410:14 amRNSExercise of Options & Rule 2.9 Announcement
16th Aug 20249:13 amRNSForm 8.5 (EPT/NON-RI)
15th Aug 202412:44 pmRNSCourt sanction of the Scheme of Arrangement
7th Aug 20246:02 pmRNSForm 8.3 - Plant Health Care Plc
7th Aug 20242:01 pmRNSForm 8.3 - Plant Health Care plc
7th Aug 20249:08 amRNSForm 8.3 - Plant Health Care PLC
6th Aug 20243:08 pmRNSResult of Court Meeting and General Meeting
6th Aug 20241:54 pmRNSForm 8.3 - Plant Health Care plc
6th Aug 202412:45 pmRNSHolding(s) in Company
5th Aug 20242:01 pmRNSForm 8.3 - Plant Health Care plc
5th Aug 20241:39 pmRNSResults of Court Meeting and General Meeting
2nd Aug 20242:00 pmRNSForm 8.3 - Plant Health Care plc
2nd Aug 20248:25 amRNSForm 8.3 - Plant Health Care PLC
1st Aug 20249:33 amRNSForm 8.3 - Plant Health Care PLC
1st Aug 20249:03 amRNSForm 8.5 (EPT/NON-RI)
1st Aug 20248:46 amRNSForm 8.3 - PLANT HEALTH CARE PLC
31st Jul 202411:21 amRNSForm 8.3 - Plant Health Care Plc
29th Jul 20241:09 pmRNSHolding(s) in Company
29th Jul 20248:51 amRNSForm 8.3 - PLANT HEALTH CARE PLC
24th Jul 20247:00 amRNSExpanded Recommendations for OBRONA
23rd Jul 20249:20 amRNSForm 8.5 (EPT/NON-RI) - Plant Health Care PLC
22nd Jul 202411:17 amRNSForm 8.5 (EPT/NON-RI)
19th Jul 20242:36 pmRNSForm 8.5 (EPT/NON-RI)
19th Jul 20242:10 pmRNSForm 8.3 - Plant Health Care plc
18th Jul 20249:05 amRNSForm 8.5 (EPT/NON-RI)
17th Jul 20249:03 amRNSForm 8.5 (EPT/NON-RI) - Plant Health Care PLC
16th Jul 20242:48 pmRNSForm 8.3 - Plant Health Care plc
16th Jul 202410:01 amRNSForm 8.5 (EPT/NON-RI)
15th Jul 202411:25 amRNSForm 8.5 (EPT/NON-RI)
15th Jul 202410:58 amRNSForm 8.3 - Plant Health Care Plc
12th Jul 20241:36 pmRNSForm 8.3 - Plant Health Care PLC
11th Jul 20242:28 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 20243:44 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 20242:58 pmRNSPublication and posting of the Scheme Document
10th Jul 20242:03 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 202410:36 amRNSForm 8 (OPD) - Plant Health Care
9th Jul 20241:57 pmRNSForm 8.3 - Plant Health Care plc
9th Jul 202410:19 amRNSForm 8.3 - Plant Health Care plc - Ospraie Ag
8th Jul 20242:00 pmRNSForm 8.3 - Plant Health Care plc
8th Jul 20241:56 pmRNSForm 8.3 - Plant Health Care Plc
4th Jul 20241:40 pmPRNForm 8.3 - Plant Health Care plc
4th Jul 202411:09 amRNSForm 8.3 - Plant Health Care PLC - Amendment
4th Jul 20248:34 amRNSForm 8.3 - Plant Health Care PLC
3rd Jul 20241:57 pmRNSForm 8.3 - Plant Health Care plc
3rd Jul 20249:26 amRNSForm 8.3 - Plant Health Care plc
3rd Jul 20249:07 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.